Norges Bank
KIN

Norges Bank’s Kindred Biosciences, Inc. KIN Stock Holding History

Norges Bank’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-215,850
Closed -$1.98M – 2381
2021
Q2 		$1.98M Buy
+215,850
New +$1.26M ﹤0.01% 2019

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Norges Bank's KIN Position: Q3 2021 in Review

Norges Bank sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 215,850 shares — an estimated $1.98M sold.

Norges Bank first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $1.98M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Norges Bank reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Norges Bank sold 215,850 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.98M.
  • Norges Bank first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Norges Bank's Kindred Biosciences, Inc. position peaked at $1.98M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.